$AXON
AXON ENTERPRISE, INC.

2022 Q4 Form 10-Q Financial Statement

#000106918322000055 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $336.1M $311.8M
YoY Change 54.49% 34.38%
Cost Of Revenue $130.5M $118.5M
YoY Change 58.1% 35.55%
Gross Profit $205.7M $193.3M
YoY Change 52.29% 33.68%
Gross Profit Margin 61.19% 61.99%
Selling, General & Admin $114.4M $102.0M
YoY Change 2.66% 2.75%
% of Gross Profit 55.63% 52.79%
Research & Development $68.72M $59.13M
YoY Change 35.61% 39.51%
% of Gross Profit 33.41% 30.6%
Depreciation & Amortization $6.210M $6.206M
YoY Change 17.75% 28.28%
% of Gross Profit 3.02% 3.21%
Operating Expenses $183.1M $161.2M
YoY Change 12.96% 13.74%
Operating Profit $22.54M $32.11M
YoY Change -183.28% 1010.97%
Interest Expense $12.19M -$11.25M
YoY Change -220.11% 103.42%
% of Operating Profit 54.07% -35.04%
Other Income/Expense, Net
YoY Change
Pretax Income $34.73M $20.86M
YoY Change -193.33% -890.08%
Income Tax $5.555M $8.727M
% Of Pretax Income 15.99% 41.84%
Net Earnings $29.18M $12.13M
YoY Change -315.98% -75.0%
Net Earnings / Revenue 8.68% 3.89%
Basic Earnings Per Share $0.17
Diluted Earnings Per Share $0.40 $0.17
COMMON SHARES
Basic Shares Outstanding 71.17M 71.11M
Diluted Shares Outstanding 72.53M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $392.9M $183.0M
YoY Change -8.31% -49.87%
Cash & Equivalents $353.7M $147.7M
Short-Term Investments $39.24M $35.28M
Other Short-Term Assets $73.02M $68.05M
YoY Change 29.15% 29.11%
Inventory $202.5M $173.0M
Prepaid Expenses
Receivables $555.1M $587.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.805B $1.206B
YoY Change 62.71% 7.29%
LONG-TERM ASSETS
Property, Plant & Equipment $169.8M $164.2M
YoY Change 22.67% 27.45%
Goodwill $44.98M $44.82M
YoY Change 3.19% 75.27%
Intangibles $12.16M $13.04M
YoY Change -21.41% 75.59%
Long-Term Investments $452.8M $318.9M
YoY Change 294.56% 195.38%
Other Assets $159.6M $110.6M
YoY Change 62.46% 20.75%
Total Long-Term Assets $1.047B $804.7M
YoY Change 80.85% 54.29%
TOTAL ASSETS
Total Short-Term Assets $1.805B $1.206B
Total Long-Term Assets $1.047B $804.7M
Total Assets $2.852B $2.010B
YoY Change 68.93% 22.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.92M $50.19M
YoY Change 85.97% 83.07%
Accrued Expenses $155.9M $112.8M
YoY Change 50.36% 26.85%
Deferred Revenue $360.0M $246.4M
YoY Change 35.56% -1.68%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $602.6M $431.5M
YoY Change 43.99% 13.59%
LONG-TERM LIABILITIES
Long-Term Debt $674.0M $0.00
YoY Change
Other Long-Term Liabilities $4.613M $4.773M
YoY Change -14.45% -84.01%
Total Long-Term Liabilities $4.613M $4.773M
YoY Change -14.45% -84.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $602.6M $431.5M
Total Long-Term Liabilities $4.613M $4.773M
Total Liabilities $1.583B $779.1M
YoY Change 147.27% 46.59%
SHAREHOLDERS EQUITY
Retained Earnings $257.0M $227.8M
YoY Change 133.91% 84.65%
Common Stock $1.175B $1.167B
YoY Change 7.25% 1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M
YoY Change 0.0% 0.0%
Treasury Stock Shares $20.22M $20.22M
Shareholders Equity $1.268B $1.231B
YoY Change
Total Liabilities & Shareholders Equity $2.852B $2.010B
YoY Change 68.93% 22.19%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $29.18M $12.13M
YoY Change -315.98% -75.0%
Depreciation, Depletion And Amortization $6.210M $6.206M
YoY Change 17.75% 28.28%
Cash From Operating Activities $131.1M $40.90M
YoY Change 914.08% 148.65%
INVESTING ACTIVITIES
Capital Expenditures $11.70M -$14.46M
YoY Change -185.89% 15.83%
Acquisitions
YoY Change
Other Investing Activities -$517.3M -$88.75M
YoY Change -399.41% -211.71%
Cash From Investing Activities -$529.0M -$103.2M
YoY Change -432.38% -254.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 600.6M -72.00K
YoY Change -717.36% -99.89%
NET CHANGE
Cash From Operating Activities 131.1M 40.90M
Cash From Investing Activities -529.0M -103.2M
Cash From Financing Activities 600.6M -72.00K
Net Change In Cash 202.7M -62.39M
YoY Change 171.03% -470.79%
FREE CASH FLOW
Cash From Operating Activities $131.1M $40.90M
Capital Expenditures $11.70M -$14.46M
Free Cash Flow $119.4M $55.36M
YoY Change 349.8% 91.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Central Index Key
EntityCentralIndexKey
0001069183
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71151670
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70896856
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16391
dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei City Area Code
CityAreaCode
480
dei Local Phone Number
LocalPhoneNumber
991-0797
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value
dei Trading Symbol
TradingSymbol
AXON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71165354
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147711000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
356332000
CY2022Q3 us-gaap Marketable Securities
MarketableSecurities
35280000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
72180000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
194627000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
14510000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2273000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2203000
CY2022Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
418308000
CY2021Q4 us-gaap Inventory Net
InventoryNet
108688000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68054000
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
320819000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
56540000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
811000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16311000
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
168673000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
180421000
CY2022Q3 us-gaap Inventory Net
InventoryNet
173046000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1205699000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1109490000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164160000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138457000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
96355000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
127193000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13039000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15470000
CY2022Q3 us-gaap Goodwill
Goodwill
44819000
CY2021Q4 us-gaap Goodwill
Goodwill
43592000
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
28536000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
31232000
CY2022Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
8462000
CY2021Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
11256000
CY2022Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
48388000
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
29753000
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
290329000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
83520000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
110643000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98247000
CY2022Q3 us-gaap Assets
Assets
2010430000
CY2021Q4 us-gaap Assets
Assets
1688210000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
50193000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32220000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
112766000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
103707000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
246446000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
265591000
CY2022Q3 axon Customer Deposit Current
CustomerDepositCurrent
15317000
CY2021Q4 axon Customer Deposit Current
CustomerDepositCurrent
10463000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6801000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6540000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
431523000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
418521000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
313823000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
185721000
CY2022Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
7317000
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3797000
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5369000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5679000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20440000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4773000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5392000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q3 us-gaap Liabilities
Liabilities
779117000
CY2021Q4 us-gaap Liabilities
Liabilities
640361000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71151670
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70896856
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1167218000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1095229000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
227847000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
109883000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7806000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1317000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1231313000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1047849000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2010430000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1688210000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118497000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87422000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
330834000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239954000
CY2022Q3 us-gaap Gross Profit
GrossProfit
193257000
CY2021Q3 us-gaap Gross Profit
GrossProfit
144567000
us-gaap Gross Profit
GrossProfit
522959000
us-gaap Gross Profit
GrossProfit
405849000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102023000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
99295000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
287157000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
403554000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59127000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42382000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165090000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143352000
us-gaap Operating Expenses
OperatingExpenses
546906000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
161150000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
141677000
us-gaap Operating Expenses
OperatingExpenses
452247000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
32107000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2890000
us-gaap Operating Income Loss
OperatingIncomeLoss
70712000
us-gaap Operating Income Loss
OperatingIncomeLoss
-141057000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11249000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5530000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
91076000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
36896000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20858000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2640000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
161788000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-104161000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8727000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-51164000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43824000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-57651000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
us-gaap Net Income Loss
NetIncomeLoss
117964000
us-gaap Net Income Loss
NetIncomeLoss
-46510000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71107000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66192000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71033000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65139000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72525000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72441000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72386000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65139000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
us-gaap Net Income Loss
NetIncomeLoss
117964000
us-gaap Net Income Loss
NetIncomeLoss
-46510000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2275000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-793000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5513000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1161000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-326000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47731000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111475000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47671000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-976000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9530000
us-gaap Share Based Compensation
ShareBasedCompensation
262221000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
30349000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-58893000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
3519000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
77000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-61000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1047849000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-70000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-1388000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25088000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
54871000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1561000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1124789000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-4000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-931000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21162000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
50962000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2327000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1193651000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-72000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28204000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2601000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1231313000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-7045000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89610000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1010904000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-3268000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
137549000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47117000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-369000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1097699000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
105615000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-172204000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35062000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-793000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1113903000
us-gaap Profit Loss
ProfitLoss
117964000
us-gaap Profit Loss
ProfitLoss
-46510000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18171000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13420000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
58000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-68000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-130000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1964000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-74000
us-gaap Gain Loss On Investments
GainLossOnInvestments
92498000
us-gaap Gain Loss On Investments
GainLossOnInvestments
34195000
us-gaap Share Based Compensation
ShareBasedCompensation
74454000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
362479000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4606000
us-gaap Operating Lease Cost
OperatingLeaseCost
4997000
us-gaap Operating Lease Cost
OperatingLeaseCost
4087000
axon Credit Loss Reserve
CreditLossReserve
569000
axon Credit Loss Reserve
CreditLossReserve
615000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
115046000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
118094000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66267000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3154000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
17871000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
28906000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28684000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28528000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
115187000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
87558000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104241000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111564000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
194142000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15485000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
499172000
axon Payments On Exercise Of Warrants Of Strategic Investment
PaymentsOnExerciseOfWarrantsOfStrategicInvestment
6555000
axon Proceeds From Equity Securities Without Readily Determinable Fair Value
ProceedsFromEquitySecuritiesWithoutReadilyDeterminableFairValue
14546000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44218000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36501000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
226000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
193000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
157000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
70500000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
20500000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2104000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
700000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-302001000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
93412000
axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
-74000
axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
105615000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2391000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
182517000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2465000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-76902000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6783000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1827000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-207008000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
126247000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356438000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155551000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149430000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
281798000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147711000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281691000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1719000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
107000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149430000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
281798000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7503000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5016000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1244000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1211000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72386000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65139000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
12131000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
48524000
us-gaap Net Income Loss
NetIncomeLoss
117964000
us-gaap Net Income Loss
NetIncomeLoss
-46510000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71107000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66192000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71033000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65139000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1418000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6249000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1353000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72525000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72441000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2977000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3481000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2952000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8920000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
axon Warranty Period After Purchase Of Product
WarrantyPeriodAfterPurchaseOfProduct
P1Y
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1988000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
582000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
161000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1176000
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
995000
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1363000
CY2022Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4000000.0
CY2021Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5300000
axon Investments In Number Of Affiliates
InvestmentsInNumberOfAffiliates
8
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
1700000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
100000
us-gaap Reclassifications
Reclassifications
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
217061000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
560269000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
228278000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
246446000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
313823000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
560269000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
265591000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
185721000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
451312000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
246446000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
313823000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
560269000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3730000000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P10Y
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
265591000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
185721000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
451312000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
462378000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
56238000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
406154000
CY2022Q3 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
147711000
CY2022Q3 us-gaap Marketable Securities
MarketableSecurities
35280000
CY2022Q3 axon Short Term Investment
ShortTermInvestment
194627000
CY2022Q3 axon Long Term Investment
LongTermInvestment
28536000
CY2022Q3 axon Fair Value Of Available For Sale Investments With Unrealized Losses
FairValueOfAvailableForSaleInvestmentsWithUnrealizedLosses
136300000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
492350000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18101000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
474254000
CY2021Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
356332000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
72180000
CY2021Q4 axon Short Term Investment
ShortTermInvestment
14510000
CY2021Q4 axon Long Term Investment
LongTermInvestment
31232000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3349000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
569000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
382000
axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
-3000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3533000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
240000000.0
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
83520000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2273000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2203000
CY2022Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1120000
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1010000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
140000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
136000
CY2022Q3 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3533000
CY2021Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3349000
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
61921000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
38267000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
111125000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
70421000
CY2022Q3 us-gaap Inventory Net
InventoryNet
173046000
CY2021Q4 us-gaap Inventory Net
InventoryNet
108688000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
236904000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
197241000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
72744000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58784000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164160000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138457000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1100000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11711000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
70856000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
20500000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
69323000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
40855000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
66630000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
290329000
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
126012000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
112233000
axon Equity Securities Without Readily Determinable Fair Value Exercises
EquitySecuritiesWithoutReadilyDeterminableFairValueExercises
66630000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
290329000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
12300000
axon Strategic Investments Unrealized Gain On Observable Price Changes
StrategicInvestmentsUnrealizedGainOnObservablePriceChanges
70400000
axon Strategic Investments Unrealized Loss On Observable Price Changes
StrategicInvestmentsUnrealizedLossOnObservablePriceChanges
1100000
axon Strategic Investments Exercise Of Warrants
StrategicInvestmentsExerciseOfWarrants
6600000
axon Strategic Investments Unrealized Gain Loss On Exercise Of Warrants
StrategicInvestmentsUnrealizedGainLossOnExerciseOfWarrants
60100000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Two
AdjustedEbitdaGoalGoalNumberTwo
155000000
CY2022Q3 axon Revenue Goal Goal Number Three
RevenueGoalGoalNumberThree
1010058000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Three
AdjustedEbitdaGoalGoalNumberThree
175000000
CY2022Q3 axon Revenue Goal Goal Number Four
RevenueGoalGoalNumberFour
1210058000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Four
AdjustedEbitdaGoalGoalNumberFour
190000000
CY2022Q3 axon Revenue Goal Goal Number Five
RevenueGoalGoalNumberFive
1410058000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Five
AdjustedEbitdaGoalGoalNumberFive
200000000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Six
AdjustedEbitdaGoalGoalNumberSix
210000000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
69058000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62425000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3918000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7152000
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
995000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3871000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3736000
CY2022Q3 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
11081000
CY2021Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
9945000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23843000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17627000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
112766000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
103707000
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
96400000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20300000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20300000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
12000000.0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.280
axon Effective Income Tax Rate Reconciliation Deduction Stockbased Compensation
EffectiveIncomeTaxRateReconciliationDeductionStockbasedCompensation
1400000
CY2018Q2 axon Market Capitalization Goal For Tranche First Tranche
MarketCapitalizationGoalForTrancheFirstTranche
2500000000
CY2018Q2 axon Market Capitalization Goal For Tranche Incremental Increase
MarketCapitalizationGoalForTrancheIncrementalIncrease
1000000000.0
CY2022Q3 axon Revenue Goal Goal Number One
RevenueGoalGoalNumberOne
710058000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number One
AdjustedEbitdaGoalGoalNumberOne
125000000
CY2022Q3 axon Revenue Goal Goal Number Two
RevenueGoalGoalNumberTwo
860058000
CY2022Q3 axon Revenue Goal Goal Number Seven
RevenueGoalGoalNumberSeven
1810058000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Seven
AdjustedEbitdaGoalGoalNumberSeven
220000000
CY2022Q3 axon Revenue Goal Goal Number Eight
RevenueGoalGoalNumberEight
2010058000
CY2022Q3 axon Adjusted Ebitda Goal Goal Number Eight
AdjustedEbitdaGoalGoalNumberEight
230000000
CY2022Q3 axon Revenue Goal Goal Number Six
RevenueGoalGoalNumberSix
1610058000
CY2022Q3 axon Maximum Ratio Of Liabilities To Tangible Net Worth
MaximumRatioOfLiabilitiesToTangibleNetWorth
2.50
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
28204000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
35062000
us-gaap Share Based Compensation
ShareBasedCompensation
74454000
us-gaap Share Based Compensation
ShareBasedCompensation
262221000
CY2022Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2
axon Product Claims Self Insurance
ProductClaimsSelfInsurance
5000000.0
CY2022Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2600000
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
8000000.0
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5600000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311754000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231989000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118497000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87422000
CY2022Q3 us-gaap Gross Profit
GrossProfit
193257000
CY2021Q3 us-gaap Gross Profit
GrossProfit
144567000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59127000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42382000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
853793000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645803000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
330834000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
239954000
us-gaap Gross Profit
GrossProfit
522959000
us-gaap Gross Profit
GrossProfit
405849000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165090000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143352000

Files In Submission

Name View Source Status
0001069183-22-000055-index-headers.html Edgar Link pending
0001069183-22-000055-index.html Edgar Link pending
0001069183-22-000055.txt Edgar Link pending
0001069183-22-000055-xbrl.zip Edgar Link pending
axon-20220930.xsd Edgar Link pending
axon-20220930x10q.htm Edgar Link pending
axon-20220930xex10d1.htm Edgar Link pending
axon-20220930xex31d1.htm Edgar Link pending
axon-20220930xex31d2.htm Edgar Link pending
axon-20220930xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
axon-20220930_def.xml Edgar Link unprocessable
axon-20220930_lab.xml Edgar Link unprocessable
axon-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
axon-20220930x10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
axon-20220930_cal.xml Edgar Link unprocessable